An alliance between German pharma group Boehringer Ingelheim and an NHS trust in the UK has been launched with the aim of reducing recurring heart attacks in people with d
More and more pharma companies are looking "beyond the pill" when it comes to providing care for patients, few more so than Eisai, which is developing a package of products and services in
Our new patient-centric world has already gone “beyond the pill”, and now it’s going beyond the patient. There’s a growing awareness that we need to look after the friends and family who ca
In a crowded marketplace, pharma companies can differentiate themselves and win support if they take actions that patients find informative and useful in managing their conditions, says Richard
After a year of high expectations, some disappointment and dramatic change, Paul Tunnah muses on three areas where the pharma industry will advance in 2017 as it looks beyond the hype.
Drug discovery is usually a goal-driven and iterative process, as researchers look for innovative new routes to target particular diseases and study those diseases in afflicted patients to learn ho